deCODE Complete
Analyzes risk factors for more than fifty common diseases and several traits, including all of those for which deCODEhealth offers individual disease tests. deCODE Complete focuses on medical conditions that can either be better prevented through altered lifestyle or that have better treatment outcomes if detected early. It is the most comprehensive genetic scan available for evaluating risk of common diseases. It is not generally reimbursable.
Diseases and conditions covered by the deCODE Complete Scan:
Abdominal Aortic Aneurysm, ABO Blood Types, Age Related Macular Degeneration, Alcohol Flush Reaction, Alzheimer’s Disease, Asthma, Atrial Fibrillation, Basal Cell Carcinoma, Bitter Taste Perception, Bladder Cancer, Brain Aneurysm, Brain Cancer-Glioma, Breast Cancer, Celiac Disease, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Chronic Obstructive Pulmonary Disease, Clopidogrel Response, Colorectal Cancer, Crohn’s Disease, Essential Tremor, Exfoliation Glaucoma, Eye Color, Gallstones, Gout, Heart Attack, Hemochromatosis, Hypertension, Kidney Stones, Lactose Intolerance, Lung Cancer, Male Pattern Baldness, Multiple Sclerosis, Nicotine Dependence, Obesity, Ovarian Cancer, Pancreatic Cancer, Peripheral Arterial Disease, Prostate Cancer, Psoriasis, Restless Legs Syndrome, Rheumatoid Arthritis, Statin Induced Myopathy, Systemic Lupus Erythematosus, Testicular Cancer, Thyroid Cancer, Type 1 Diabetes, Type 2 Diabetes, Ulcerative Colitis, Venous Thromboembolism, Warfarin Metabolism.
Prostate Cancer
Dr. William Catalona talks about genetic tests and Prostate Cancer
Genetic variants are a significant contributor to the risk of developing prostate cancer; in fact, of all cancer types, prostate cancer is most closely linked to genetic risk factors.
Realizing one’s overall risk, including genetic risk, is the first step in making an informed decision about when to seek medical advice.
Early diagnosis is the key to beating prostate cancer.
Empower your preventive actions with the deCODEhealth genetic risk assessment for prostate cancer
The prostate is part of the male reproductive system
The male prostate is normally a small gland, about the size of a walnut, located under the urine bladder. The prostate is part of the male reproductive system it makes part of the seminal fluid needed to carry sperm out of the man’s body. The urethra, the narrow tube that runs the length of the penis and carries both urine and semen out of the body, runs directly through the prostate. This is why the first signs of prostate enlargement are often related to urinary problems.
Chuck and Dr. Bale are convinced that the deCODEme genetic test saved Chuck’s life. Click on the picture to watch Chuck’s story
Prostate cancer is typically a slow growing cancer
Prostate growths can be benign (not cancer) or malignant (cancer). Prostate cancer occurs when cells within the prostate start to multiply uncontrollably. In most cases, prostate cancer is a relatively slow-growing cancer, which means that it takes a number of years to become detectable. A small percentage of prostate cancers however, grow more rapidly. Unfortunately, it is difficult to predict which prostate cancers will grow slowly and which will grow more aggressively.
If detected early, prostate cancer is highly curable
In early stages of prostate cancer, while the tumors are enclosed within the prostate, the disease is often curable with cure rates of 90% or more. Unfortunately, at this highly curable stage, prostate cancer produces few or no symptoms and can be difficult to detect. In general, the earlier the prostate cancer is caught, the more likely it is that treatment will be successful.
Prostate cancer is the most common non-skin cancer among men
During their lifetimes, one in six men will be diagnosed with prostate cancer (lifetime risk of 16%), and 1 in 33 men will die of the disease (3% lifetime risk). Over 200,000 new cases of prostate cancer will be diagnosed, and prostate cancer will lead to approximately 27,000 deaths in the US this year. A man is over 30% more likely to be diagnosed with prostate cancer in his lifetime than a woman is to be diagnosed with breast cancer in hers.
Genetics contribute significantly to prostate cancer risk
Genetic variants are a significant contributor to the risk of developing prostate cancer; in fact, of all cancer types, prostate cancer is most closely linked to genetic risk factors. Several, relatively common, genetic variants are known to increase the risk of developing prostate cancer.
deCODEhealth calculates your patients’ genetic risk for prostate cancer
The deCODE Complete Scan identifies validated prostate cancer risk variants and uses them to provide a personalized interpretation of the associated genetic risk for the disease. The number of variants included in the deCODE Complete Scan for each ethnic group are listed in the table below.
| Number of Variants Measured | |
|---|---|
| European ancestry | 29 |
| East Asian ancestry | 15 |
| African ancestry | 10 |
At present, the necessary scientific information to interpret the genetic risk for individuals of other ethnicities is not available. This information will be added as soon as it becomes available and we are assured of its quality.
This content was last reviewed on February 20, 2012.